Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ACTRN12626000650392) titled 'A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interactions of NB-9402 in Healthy Adult Volunteers - Part A and B' on June 1.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety
Primary Sponsor: Nura Bio Inc
Condition:
Diseases of the nervous system
Diseases of the nervous system
Neurological - Other neurological disorders
Intervention:
Part A - Single Ascending Dose (SAD).
5 cohorts of 7 participants each will receive either NB-9402 or place...